Is pioglitazone a viable option for patients with insulin resistance and recent stroke or myocardial infarction?

Can DPP-4 inhibitors and GLP-1 analogues cause bile duct and gallbladder complications?

A team of researchers at the University of Wisconsin School of Medicine and Public Health has identified the genetic cause for a rare syndrome in children with poorly controlled type 1 diabetes.

In part 3 of this exclusive interview, Dr. Faustman discusses how a cure based on the inexpensive BCG vaccine could permanently change type 1 treatment, and whether results could also apply to type 2.

In part 2 of this exclusive interview, Dr. Faustman discusses the challenges of dosing BCG correctly, and the difficulties of defeating autoimmunity in humans.

In part 1 of this exclusive interview, Dr. Faustman discusses her research and why an old tuberculosis vaccine may lead us to a cure for type 1.

When the Biosimilar insulin to Lantus becomes available for about 10-15% less cost, will you recommend it to your patients? Follow the link to share your opinion!

Weight loss has been shown to have a positive impact on glucose control and cardiovascular risk factors. At which weight loss threshold do these positive benefits start to become meaningfully apparent? A) Weight reduction of 0-4% B) Weight reduction of 5-10% C) Weight reduction of 11-15% D) Weight reduction of 16-20% Did you get it right? Follow the link to find out!

For years the crux of diabetes care for type 2’s has been to reduce the amount of glucose going in and the amount of glucose being absorbed. We put patients on carbohydrate-restricted diets, have them take fiber before a meal, and use medicines such as acarbose. For the most part …

If you are still stuck on the “metformin to start with and max out the dose” diabetes treatment algorithm, then you’d better take a look at this week’s homerun slides. Considering there are 11 distinct pathways to developing diabetes, it doesn’t make any sense that all our patients would only have …